baber/WOPTO huggingface dataset:
Patent JP-2002503365-A (JP)
Title: 一意的にカスタマイズされ、認証かつ追跡可能なソフトウェア・アプリケーションのネットワーク化インストール方法およびシステム
IPC: G06F9/445
Filed: 1998-03-18
Abstract: (57)【要約】
特定ユーザが認証かつ追跡できるような、一意にカスタマイズされた、ソフトウェア・アプリケーションのインスタンスを生成し、配信し、そして、インストール・コンピュータにインストールする方法である。配信コンピュータに常駐するセキュア配信エージェントは、識別情報を収集し、ソフトウェア・アプリケーションの暗号化署名と識別情報を計算する。これら識別情報と暗号化署名は、セキュア配信エージェントによって、ソフトウェア・アプリケーションに組み込まれる。組み込みデータを有するソフトウェア・アプリケーションは、配信チャネルを介してインストール・コンピュータへ送信される。インストール・コンピュータに常駐するユーザ・インストール・エージェントは、インストール・コンピュータにおける、組み込みデータを有するソフトウェア・アプリケーションのインストールを管理する。インストール前に、ユーザ・インストール・エージェントは、暗号化署名を用いて、ソフトウェア・アプリケーションと識別情報とが信頼でき、かつ、改ざんされていないことを確認する。
Patent JP-2002501581-A (JP)
Title: ポリエステルフィラメントを前接着処理する方法
IPC: D06M13/328
Filed: 1998-04-06
Abstract: (57)【要約】
本発明は、ポリエステルフィラメントを、ゴムとの接着特性を改良するために、前接着処理剤の成分（Ａ）及び（Ｂ）を連続したフィラメント糸に別々に塗布することによって、前接着処理する方法に関する。本発明の方法は、フィラメントの生産のためのより一層十分に長い運転時間及び結果としてのより一層高い生産性を可能にする。
Patent JP-2001520585-A (JP)
Title: 無鉛ハンダ
IPC: B23K35/26
Filed: 1998-04-22
Abstract: (57)【要約】
ビスマスを１５．０から３０．０％と銀を１．０から３．０％含みそして場合により銅を０から２．０％そしてアンチモンおよび付随的不純物を０から４．０％含んでいてもよくそしてその残りが錫であるハンダ組成物。
Patent JP-2001521572-A (JP)
Title: 表面を変性された酸化物または珪質の充填剤およびその使用
IPC: C08K9/04
Filed: 1998-04-14
Abstract: (57)【要約】
酸化物または珪酸塩系の充填材料をヒドロキシル基含有不飽和化合物を用いてエステル化し、硫黄または硫黄供与体で処理することにより表面を処理された酸化物または珪酸塩系の充填材料が製造される。この際これらの反応は相次いで或いは一緒に行うことができる。これらの変性された充填材料を用いて得られたゴム混合物はローリング抵抗が低く摩耗耐性が高い高度に補強された摩耗耐性をもつ成型品の製造に適している。
Patent MX-153055-A (MX)
Inventor: COCHRAN WILLIAM THOMAS
IPC: H04M19/02
Filed: 1983-04-20
Abstract: The digital supervisory circuit comprises an amplitude comparator and EXCLUSIVE-OR gate to provide an output signal indicating the difference in time an input signal is above and below a predetermined reference potential. This output signal is integrated in an up-down binary counter and also is coupled to a first logic circuit under control of the counter which provides a ring present supervisory signal when a first threshold is exceeded and a second logic circuit under control of the counter which provides a switch hook detection supervisory signal when a second threshold is exceeded. A hit-timing circuit is provided coupled to the counter and the first and second logic circuits to prevent response of the counter and second logic circuit to line transients.
Patent MX-155858-A (MX)
Inventor: O'BRIEN THOMAS E JR
IPC: H04N7/16
Filed: 1984-06-08
Abstract: An addressable CATV converter for connection with a remote headend in a cable distribution system contains a memory into which a unique address code identifying that converter is downloaded from the remote headend.
Patent MX-162565-A (MX)
Inventor: SEGMAN RICHARD WILLIAM
IPC: C07C51/56
Filed: 1985-08-15
Abstract: @ A process for the production of organic carboxylic anhydrides by the catalytic reaction of a methyl carboxylate and carbon monoxide in contact with a homogeneous catalyst system of rhodium metal atom, a phosphorus-containing ligand in which there is present at least one oxo (=0) oxygen atom attached to a phosphorus atom or a carbon atom to form a Z group and thegroup in said Z group is located at least one carbon atom removed and preferably from 2-4 carbon atoms removed from the phosphorus atom of the molecules represented by the formulasorand a halogen source, under mild reaction conditions, wherein R' is aryl, alKaryl, aralkyl or alkyl, and wherein 1 or more of said R' groups can be substituted with a Z group but not more than 3 of said R' groups in the molecule are so substituted; a is an integer from 0-4; b is an integer from 0-3 and Z is P(O)R'R'; - C(O)OR" or C(O)R", wherein R" is R or -H.
Patent NZ-199071-A (NZ)
Title: Surgical dressing activated charcoal impregnated with anti-microbial agent
Inventor: JACKSON S W
IPC: A61L15/18
Filed: 1981-11-25
Abstract: A surgical dressing comprises activated charcoal, preferably as activated charcoal cloth, which is impregnated with an anti-microbial agent, the adsorptive sites of the activated charcoal being no more than 20% saturated with the anti-microbial agent. The antimicrobial agent is preferably iodine, in an amount which causes approximately 5% saturation of the adsorptive sites of the activated charcoal. An alternative dressing comprises a foamed elastomer filled with activated charcoal powder which has been impregnated up to 20% saturation with anti-microbial agent.
Patent NZ-201625-A (NZ)
Title: Polyurethanes with increased structural properties
Inventor: GOLDWASSER D J
IPC: C08G18/76
Filed: 1982-08-18
Abstract: Polyurethane resins are described having high impact strength and other structural strength properties, and significantly improved resistance to deformation by heat. The properties of these materials are such as to make them comparable to engineering thermoplastics such as nylon and like materials commonly used to fabricate structural components such as automotive parts, equipment housing, sporting goods, furniture, toys, household and like consumer goods. The resins are prepared from organic polyisocyanates, an isocyanate-reactive material (polyol, polyamine, etc.) having an average functionality of at least 1.9, a Tg less than 20 DEG  C. and molecular weight of 500-20,000, and one or more low molecular weight extenders the major distinguishing feature being the markedly lower proportion by weight (2 to 25 percent) in which the isocyanate-reactive material is employed as compared with polyurethane resins conventionally prepared in the art. Depending upon the particular combination of reactants employed the polyurethanes of the invention can be thermoplastic or thermoset and can be prepared in both cellular and non-cellular form.
Patent NZ-202973-A (NZ)
Title: Pipelaying appliance coupled to excavator bucket
Inventor: SONERUD J T
IPC: F16L1/06
Filed: 1983-01-07
Abstract: A pipelaying appliance (1) is removably connected to the bucket (2) of an excavator with the aid of a gripping means (3) mounted on the bucket. The appliance includes two gripping arms (7, 8) of which one thrusts into the pipe (9) and the other is situated on the outside of the pipe. The gripping arms are movable to and from each other and are connected to the appliance so that the clamping force of the gripping arms on the pipe wall will be proportional to the weight of the pipe carried by the appliance.
Patent NZ-224715-A (NZ)
Title: Mixed crystals of insulin and insulin derivatives, pharmaceutical compositions and methods of preparation
Inventor: DORSCHUG MICHAEL
IPC: A61P3/08
Filed: 1988-05-20
Abstract: Mixed crystals composed of (a) unmodified insulin, des-Phe-B1 insulin, des-Thr-B30 (human) or des-Ala-B30 (pork, beef) insulin and (b) least one insulin having a basic modification at the C-terminal end of the B chain, preferably composed of human insulin and Arg-B31 human insulin and/or Arg2-(B31-32) human insulin. These mixed crystals are obtained by crystallization from aqueous solution within a narrow pH range (from about 5.5 to about 6.9). The mixed crystals show a specific moderately prolonged profile and are suitable for the treatment of diabetes mellitus.
Patent NZ-231944-A (NZ)
Title: Arg ao -insulin derivatives and pharmaceutical compositions containing these
Inventor: VERTESY LASZLO
IPC: C07K14/62
Filed: 1989-12-21
Abstract: Insulin derivatives with a basic modification owing to the basic amino acid arginine in position A0 of the formula II <IMAGE>  in which  a) R<3><0> + R<3><1> together = OH or b) R<3><0> = residue of a neutral, genetically encodable L-amino acid and R<3><1> = OH or a physiologically acceptable organic group which is basic in nature and has up to 50 C atoms, in whose structure 0 to 3  alpha -amino acids are involved and whose terminal carboxyl group, which is present where appropriate, can be free, as ester function, as amide function, as lactone or reduced to CH2OH, with the exception of the case in which, at the same time, R<3><0> = Ala, R<3><1> = OH and the A and B chain are the sequences of bovine insulin, and the physiologically tolerated salts thereof are obtained by various processes. The compounds are suitable for the treatment of diabetes mellitus, have a delayed profile of action and are very well tolerated.
Patent NZ-252526-A (NZ)
Title: Solid dosage form containing one or more amino acids in a matrix material comprising gelatin, pectin, and/or soy fibre protein and which disperses rapidly in water
Inventor: LEVINSON R SAUL
IPC: A23L27/00
Filed: 1993-05-03
Abstract: A fast dissolving, solid dosage form defined by a matrix containing gelatin, pectin and/or soy fiber protein and one or more amino acids having from about 2 to 12 carbon atoms.
Patent NZ-256444-A (NZ)
Title: Stereoselective preparation of a beta-phenylisoserine; its use in preparing correspondingly substituted taxane derivatives
Inventor: DENIS JEAN-NOEL
IPC: C07C251/28
Filed: 1993-10-04
Abstract: PCT No. PCT/FR93/00966 Sec. 371 Date Apr. 5, 1995 Sec. 102(e) Date Apr. 5, 1995 PCT Filed Oct. 4, 1993 PCT Pub. No. WO94/07847 PCT Pub. Date Apr. 14, 1994This invention relates to a method of stereoselective preparation of a derivative of  beta -phenylisoserine of formula (I) by the action of an N-carbonyl-benzylimine of formula (II) on an optically active amide of a protected hydroxyacetic acid of formula (III), followed by hydrolysis of the product obtained. In formula (I), (II) or (III), R is an optionally substituted phenyl radical or R1-O, Ar is an optionally substituted aryl radical and G1 is a hydroxy function protection grouping. The product of formula (I) is particularly useful in preparing taxol and Taxotere which have remarkable antitumor properties.    <IMAGE>  (I)  ArCHNCOR (II)   <IMAGE>  (III)
Patent NZ-270403-A (NZ)
Title: Medicament inhaler; method and apparatus in which a capsule containing powered medicament is present in an inhalation tube, tube has air inlets downstream of capsule
Inventor: VILLAX PETER
IPC: A61M16/00
Filed: 1995-01-26
Abstract: A new inhalation device, which during operation causes an aerosol to be formed inside a chamber such as a capsule (4) which occludes one end (3) of the inhalation tube (1), the capsule having holes at its extremities (7,8) which admit airflow. The airflow causes the powder contained inside the capsule to be surprisingly transported to the capsule extremity contrary to the direction of inhalation, that is towards the air entry holes in the capsule, and then to form an aerosol until all powder has been removed from the capsule or chamber through the tube (1), the duration of inhalation being chiefly regulated by the size and proportion of the capsule holes. The tube (1) has air inlets downstream of the capsule to permit a balanced airflow that will transport the finely suspended powder into the lungs, maximizing the fraction of medicament deposited therein. <IMAGE>
Patent NZ-331702-A (NZ)
Title: An extrusion method, an extruder and a product whereby the extruder has a conical stator and rotor, diagonally positioned bearings and slip agent
Inventor: KIRJAVAINEN KARI
IPC: B29C48/06
Filed: 1997-04-04
Abstract: The extruder comprises at least one conical stator (1, 2) and at least one rotatable conical rotor (3).  The rotor (3) is mounted from its widest point with bearings (12a, 12b) in such a way that the first bearing (12a) receives the forces acting in one axial direction of the rotor (3) and the second bearing (12b) receives the forces acting in the opposite axial direction of the rotor (3).  The invention provides a very firm bearing arrangement, whereupon it is also possible to produce an extruded product that contains at least 0.5 % of a slip agent and substantially no weld lines.  An extrusion method is also claimed.
Patent NZ-333652-A (NZ)
Title: Inhibition of human rotavirus infection using kappa-casein
Inventor: MUKERJI PRADIP
IPC: A61K38/17
Filed: 1999-01-06
Abstract: This use of native or recombinant unhydrolyzed human or bovine k-casein (kappa-casein) is in medicaments for treating or retarding the onset of human rotavirus.
Patent NZ-334376-A (NZ)
Title: Transmitting, a portion of accumulated data, from vehicles in response to instruction from a data processing station
Inventor: HARRISON CHRISTOPHER GERARD
IPC: G08G1/127
Filed: 1997-09-16
Abstract: A data monitoring apparatus uses a GPS receiver, micro controller, a plurality of sensors and actuators, a memory, a radio transmitter and a data communication antennae. The apparatus accumulates real-time data concerning position and time and other operational parameters of a geographically mobile object for example a vehicle for transmission to a monitoring station. Transmission channel utility may be improved through transmission of accumulated historical data to a separate monitoring station.
Patent NZ-334564-A (NZ)
Title: Switching cabinet
Inventor: NICOLAI WALTER
IPC: H02B1/01
Filed: 1997-11-06
Abstract: The invention relates to a switching cabinet comprising a rack endowed with horizontal and vertical frame profiles (11, 12, 30).  The horizontal frame profiles (11, 12) form a lower and upper frame (10) and the vertical frame profiles (30) are secured in the corner areas of the upper and lower frames.   The vertical frame profiles (30) are symmetrical to the cross-sectional diagonals running across the virtual, vertical outer edges of the rack.  Greater flexibility in installing built-in fixtures inside the switch cabinet is achieved by providing the vertical frame profiles (30) which are turned towards the inside of the switching cabinet with an open inner cavity consisting of two inner walls (33, 34) extending in the longitudinal direction of the profiles so that vertical assembly rails (50) can be mounted in the inner cavity (35.1).  One profiled side (31, 32) standing perpendicular to the outside of the rack is joined to the inner walls.  The inner walls (33, 34), the assembly rails (50) and the profiled sides can be fitted with rows of fastening cavities (56, 57) inserted according to a divisional grid. The inner walls (33, 34), the assembly racks and the profiled sides (31, 32) are provided with rows of attachment cavities (37, 37.1) installed in the division grid.
Patent NZ-505250-A (NZ)
Title: Novel triazolo(4,5-d) pyrimidine compounds and pharmaceuticals thereof.
Inventor: BROWN ROGER
IPC: A61P7/02
Filed: 1999-02-05
Abstract: A compound of formula (I), wherein; R1 is an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl or thienyl group; R2 is an optionally substituted alkyl, alkenyl or cycloalkyl: R3 and R4 are both hydroxy; R5 is hydrogen or C1-6 alkyl; R6 is an optionally substituted alkyl. Also described is a pharmaceutical composition useful in the treatment of myocardial infarction or unstable angina.
Patent NZ-505983-A (NZ)
Title: An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition
Inventor: ANDREASEN HANS BERG
IPC: A61K47/48
Filed: 1999-03-24
Abstract: Described is an iron-dextran compound comprising hydrogenated dextran in stable association with ferric oxyhydroxide.  The hydrogenated dextran has a weight average molecular weight (Mw) between 700 and 1,400 Daltons, and a number average molecular weight (Mn) between 400 and 1,400 Daltons.  90% by weight of the dextran has molecular weights less than 2,700 Daltons and the Mw of the 10% fraction of the dextran having the highest molecular weights is below 3,200 Daltons.  The hydrogenated dextran is subjected to purification by membrane processes having a cut-off value between 340 and 800 Daltons to remove molecules below this cut-off value. The above-described compound is useful for the prophylaxis or treatment of iron-deficiency anaemia in animal or human subjects. Also described is a dextran compound comprising hydrogenated dextran with a weight average molecular weight (Mw) between 700 and 1,400 Daltons, and a number average molecular weight (Mn) between 400 and 1,400 Daltons.  90% by weight of the dextran has molecular weights less than 2,700 Daltons and the Mw of the 10% fraction of the dextran having the highest molecular weights is below 3,200 Daltons.  The hydrogenated dextran is subjected to purification by membrane processes having a cut-off value between 340 and 800 Daltons to remove molecules below this cut-off value.
Patent NZ-507106-A (NZ)
Title: Preparation of cyclohexene carboxylate derivatives
Inventor: KIM CHOUNG U
IPC: C07C227/16
Filed: 1997-08-22
Abstract: A process for preparing compounds of formula (51) comprises reacting a compound of formula (50) with an oxidizing reagent wherein: R2 is a carboxylic acid protecting group; R4 is -C(R30)3 provided that R4, taken as a whole, contains 0 to 3 W groups substituted with 0 to 3 R29 groups and in addition 1 to 12 carbon atoms substituted with 0 to 3 R22 groups. each R20 is independently H or alkyl; each R21 is independently R20, Br, Cl, F, I, CN, NO2 or N3; each R30 is independently H, R24, W or R24aW; W is optionally substituted carbocyclic or heterocyclic radical; R24 is independently R23 wherein each R23 is substituted with 0 to 3 R22 groups; R24a is optionally substituted independently alkylene, alkenylene or alkynylene; R23 is independently alkyl, alkenyl or alkynyl Y1 is a mono-, di- or unsubstituted amino group and each R22 and R29 are as defined in the specification. A process for preparing compounds of formula (61) comprises reacting a compound of formula (51) with a base wherein R2, R4, R21, R20 and Y1 are as defined above.
Patent NZ-508458-A (NZ)
Title: Spray-coating and/or brush-coating hard-boiled sweets with a solid fat or fat derivative to prevent stickiness
Inventor: SOLDANI CRISTIANA
IPC: A23P20/10
Filed: 2000-11-27
Abstract: A coated high-boiled confection wherein the coating comprises a solid fat or fat derivative having a melting point of from 25oC to 65oC; and a method for preparing this high-boiled confection by applying the coating in melted form to the surface of the high-boiled confection and cooling to solidify the coating.
Patent NZ-511560-A (NZ)
Title: A method for the assessment of particles and a system and a device for use in the method
Inventor: GLENSBJERG MARTIN
IPC: G01N33/48
Filed: 1999-11-05
Abstract: Disclosed is a method and a device for the assessment of at least one parameter of particles in a liquid analyte material, comprising providing a device comprising a sample compartment comprising an exposing domain, an inlet through which a volume of a liquid sample representing the analyte material can be introduced, and a flow system comprising at least a channel allowing at least a portion of the volume of the liquid sample to flow within the device. A volume of the liquid sample is introduced in the device through the inlet of the disposable device, passing at least a portion of the volume of the liquid sample through the flow system of the device into the exposing domain of the sample compartment, arranging the device in relation to detection device comprising a detection means for quantitatively detecting spatial image data and processing means for processing the detected image presentation detecting electromagnetic signals from the sample in the exposing domain of the device in the detection device forming, in the detection device, a spatial image representation of the exposing domain, and processing the detected image presentation obtaining the assessment of the at least one parameter.
Patent NZ-511683-A (NZ)
Title: Nucleotide and protein sequences of nogo genes and methods based thereon for treatment of diseases that result in damage to the central system
Inventor: SCHWAB MARTIN E
IPC: C12N5/10
Filed: 1999-11-05
Abstract: Described are the gene, Nogo, its encoded protein products, as well as derivatives and analogues thereof. Production of Nogo proteins, derivatives, and antibodies is also provided as are therapeutic compositions and methods of diagnosis and therapy for diseases, disorders or damage that ultimately result in damage of the nervous system; such diseases, disorders or damage include central nervous system (CNS) trauma, (e. g. spinal cord or brain injuries), infarction, infection, malignancy, exposure to toxic agents, nutritional deficiency, paraneoplastic syndromes, and degenerative nerve diseases (including but not limited to Alzheimer's disease, Parkinson's disease, Huntington's Chorea, multiple sclerosis, amyotrophic lateral sclerosis, and progressive supra-nuclear palsy); by administering compounds that interfere with Nogo activity (e. g., a dominant negative Nogo derivative; antibodies to Nogo; anti-sense nucleic acids of Nogo; Nogo ribozymes or chemical groups that bind an active site of Nogo).
Patent NZ-516889-A (NZ)
Title: Pharmaceutical compounds useful in oxidative stress and/or endothelial dysfunction of moderate intensity
Inventor: DEL SOLDATO PIERO
IPC: C07D401/00
Filed: 2000-07-27
Abstract: Disclosed herein are compounds or their salts of general formula (I): A-B-N(O)s wherein: s is 2; A = R-T1-, wherein T1 = O or NH and R is the drug radical as defined in the specification; B = -TB -X2-O-, wherein TB = (CO), X2 is a bivalent radical such that the precursor drug compound of B meets the pharmacological tests described in the description.
Patent NZ-521090-A (NZ)
Title: 7-(pyrazole-3-yl) benzoxazole derivatives, method for their production, use as herbicides
Inventor: ZAGAR CYRILL
IPC: C07D413/14
Filed: 2001-03-15
Abstract: A method for producing 7-(pyrazole-3-yl) benzoxazoles of formula (I) is disclosed, wherein the variables R1 to R6 are as defined in the specification. The method comprises reacting a 2-halogen-3-(pyrazole-3-yl) anilide of formula (II), in which X represents bromine or iodine, with a base in the presence of copper (I) compound, wherein the ration of copper (I) compound to the compound of formula (II) is less than 1:1.
Patent NZ-524640-A (NZ)
Title: Bricklaying structure, Bricklaying method and Brick manufacturing method
Inventor: MATSUFUJI YASUNORI
IPC: E04B2/42
Filed: 2001-09-05
Abstract: A bricklaying structure, a bricklaying method and a brick manufacturing method that is adaptable to a variety of architectural details. Each brick is provided with a bolt hole and through-holes. The bolt hole has a diameter which allows a bolt to extend there through and the through-hole has a diameter for containing a nut. The bolt hole and through-holes are arranged on a longitudinal centre line of the brick in order, and a centre of the bolt hole, centres of the through-holes and respective end faces of the brick are spaced apart an equal distance from each other in a longitudinal direction of the brick. The bricks and metallic plates are vertically stacked and the bricks are integrally connected under pre-stress with each other by tightening the bolts extending through the vertical bolt holes.
Patent NZ-528361-A (NZ)
Title: Methods and apparatus for packing chromatography columns and chromatography column
Inventor: HOFMANN MARTIN JOHN
IPC: G01N30/50
Filed: 2001-07-30
Abstract: Ultrasound transceivers (20) are distributed up the side wall of a chromatography column (1) and enable tracking of the progress of a rising bed front (5) during packing. Comparison with a predetermined stored profile is used for feedback control of the packing pump P. Other uses of ultrasound monitoring of the column interior are disclosed. This invention is directed at using ultrasound for enhanced packaging and control or automation. (62) Divided out of 517979